SARS-CoV-2

UF biostatisticians estimate what the delta variant-driven surge in COVID-19 infections may look like in Florida in the coming months.

A team of UF researchers has identified dozens of novel therapeutic targets for the development of antiviral therapies against COVID-19 and other coronaviruses that infect people.

UF’s EPI is partnering with Gainesville-based tech company SurfPlasma, Inc. to test a new device’s ability to kill pathogens — even the celestial kinds.

Recent work contributed to by UF mathematician Burton Singer seeks to estimate how COVID-19 vaccination campaigns will affect the future trajectory of the pandemic in the US.

UF researchers collected the virus that causes COVID-19 from air within a car that was driven by someone with mild symptoms — but who was not wearing a face mask.

A UF meta-analysis uncovers transmission patterns of SARS-CoV-2 within households.

Which global distribution strategy for a hypothetical COVID-19 vaccine will save the most lives?

UF researchers Chang-Yu Wu, an engineer, and John Lednicky, a virologist, teamed up a decade ago to solve long-standing challenges in how air samples are collected and tested for viruses. Few people grasped the public health value of their work until a novel respiratory virus gave rise to the COVID-19 pandemic.

A plaque, or area of destroyed cells in a cell culture shows the presence of an active SARS-CoV-2 infection. (Image courtesy of Mike Norris) A University of Florida research team is harnessing the power of genomic editing to illuminate druggable targets in human cells for the fight against…

A new EPI analysis examines COVID-19 statewide cases by age, plus health care trends at the state and county level.